You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PD-1(L1)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Classical Hodgkin Lymphoma Trial in Chicago, Detroit, Seattle (Tenalisib, Pembrolizumab)

Terminated
  • Classical Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
Dec 24, 2019

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

QOL After SURGERY and ADJUVANT Treatment

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Quality of Life
  • Questionnaires
  • Salamanca, Spain
    Hospital Clínico Universitario
Oct 30, 2023

Gingival Recession, Localized, Tooth Abrasion Trial in São José Dos Campos (procedure, device, drug)

Recruiting
  • Gingival Recession, Localized
  • Tooth Abrasion
  • Restorative procedure
  • +4 more
  • São José Dos Campos, SP, Brazil
    Sao Paulo State University
Jun 22, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial run by the NCI (AMP-224, Stereotactic Body Radiation

Completed
Has Results
  • Colorectal Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 12, 2019

Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

Not yet recruiting
  • Cancer
  • +16 more
  • KVA12123 - Dose Escalation
  • +3 more
  • (no location specified)
Feb 2, 2023

SOGUG-AVELUMAB_RWD

Recruiting
  • Metastatic Urothelial Carcinoma
  • Vigo, Pontevedra, Spain
  • +21 more
Jan 17, 2023

Locally Advanced Resectable Esophageal Squamous Cell Carcinoma Trial in Shanghai (SHR-1210)

Not yet recruiting
  • Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 5, 2021

Esophageal Squamous Cell Carcinoma Trial in Hangzhou (biological, drug, radiation)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • Sintilimab
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 5, 2019

Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine, Placebo)

Completed
  • Symptomatic Neurogenic Orthostatic Hypotension
  • Sun City, Arizona
  • +124 more
Sep 15, 2021

Post-ERCP Pancreatitis Trial in Lexington (Use of different concentrations of oxygen during ERCP)

Completed
  • Post-ERCP Pancreatitis
  • Use of different concentrations of oxygen during ERCP
  • Lexington, Kentucky
    University of Kentucky
Nov 1, 2022

Metastatic Colorectal Cancer Trial in Guangzhou (SHR-1210, BP102, oxaliplatin)

Terminated
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
May 8, 2019

Parkinson Disease Trial in Campobasso (Strenght training combined with WB-EMS, Cardiovascular training with WB-EMS, Control

Enrolling by invitation
  • Parkinson Disease
  • Strenght training combined with WB-EMS
  • +2 more
  • Campobasso, Italy
    Università degli Studi del Molise
Feb 1, 2023

PK, PD, and Safety Trial in Beijing (N11005, Novolin R)

Completed
  • PK, PD, and Safety
  • Beijing, China
    Beijing Hospital
Jul 22, 2021

Developmental Endothelial Locus-1, Platelet Count, and Soluble

Not yet recruiting
  • Overweight and Obesity
  • Platelet count
  • +2 more
  • Aswan, Egypt
    Aswan University Hospital
May 17, 2023

Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • CD19x22 CAR T Cells
  • Aurora, Colorado
    University of Colorado Hospital
Sep 1, 2022

Persistent Diarrhea Trial in Dhaka (GB mixed full strength rice suji, Full strength rice suji Alone, 3/4th strength rice suji)

Unknown status
  • Persistent Diarrhea
  • GB mixed full strength rice suji
  • +2 more
  • Dhaka, Bangladesh
    Dhaka Hospital, icddr,b
Feb 16, 2021

Ovarian Cancer Trial in Worldwide (Carboplatin, Pegylated Lipoxomal Doxorubicin (PLD), Trabectedin)

Completed
  • Ovarian Cancer
  • Graz, AT, Austria
  • +131 more
Feb 8, 2022

Acute Ischemic Stroke Trial in China (rt-PA, rhTNK-tPA)

Completed
  • Acute Ischemic Stroke
  • Hefei, Anhui, China
  • +60 more
Jan 13, 2023

Time in Range Trial in Cairo (Dipeptidyl peptidase-4 inhibitors)

Completed
  • Time in Range
  • Dipeptidyl peptidase-4 inhibitors
  • Cairo, Egypt
    Nancy Elbarbary
Aug 26, 2023

Head Neck Cancer Trial in Baltimore, Chapel Hill, Philadelphia (Pembrolizumab, Intensity Modulated Radiation Therapy)

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Baltimore, Maryland
  • +2 more
Dec 7, 2022

Parkinson Disease Trial in Houston (PRIM-DJ2727, Placebo oral capsule)

Active, not recruiting
  • Parkinson Disease
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Dec 23, 2021

Emphysema Trial in Belgium, Switzerland (Lung volume reduction surgery, Bronchoscopic lung volume reduction with valves)

Recruiting
  • Emphysema
  • Lung volume reduction surgery
  • Bronchoscopic lung volume reduction with valves
  • Leuven, Belgium
  • +3 more
May 23, 2022

Desmoplastic/Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma With Extensive Nodularity Trial in Worldwide

Active, not recruiting
Has Results
  • Desmoplastic/Nodular Medulloblastoma
  • +4 more
  • Birmingham, Alabama
  • +172 more
Jan 4, 2022